More evidence supports BP-lowering in type 2 diabetes

ADVANCE trial data suggests antihypertensives beneficial across a range of baseline characteristics

Intensified BP-lowering therapy cuts mortality and major vascular events in patients with type 2 diabetes, regardless of their baseline blood pressure or CVD risk, trial results show.